The technology optimizes the microstructure of biomaterials to enable greater strength gain in resorbable implantables. It offers a platform upon which to develop next generation resorbable orthopedic products.
Proxy Biomedical is a company that focuses on biomaterial solutions for medical implantable products.
More articles on devices:
Smith & Nephew shares lost 7.14% last week — 5 key updates
Stryker shares drop 4.94% in 7 days: 5 things to know
Minimus Spine receives U.S. patent — 5 things to know
